Tzogani, K., Florez, B., Markey, G., Caleno, M., Olimpieri, O. M., Melchiorri, D., . . . Pignatti, F. (2019). European Medicines Agency review of ixazomib (Ninlaro) for the treatment of adult patients with multiple myeloma who have received at least one prior therapy. ESMO Open.
استشهاد بنمط شيكاغوTzogani, Kyriaki, et al. "European Medicines Agency Review of Ixazomib (Ninlaro) for the Treatment of Adult Patients With Multiple Myeloma Who Have Received At Least One Prior Therapy." ESMO Open 2019.
MLA استشهادTzogani, Kyriaki, et al. "European Medicines Agency Review of Ixazomib (Ninlaro) for the Treatment of Adult Patients With Multiple Myeloma Who Have Received At Least One Prior Therapy." ESMO Open 2019.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.